Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

BCAB

BioAtla, Inc.

CIK 0001826892 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$3.18
↑ 0.00 (0.00%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: BullishOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership; Excluded: Options (no data)

Key stats

Market Cap
$5.30M
P/E Ratio
-0.17
EPS
-1.01
Dividend Yield
Not covered
52W Position
48%
Beta
0.41

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-0.15
P/S
Not covered
EV/Revenue
Not covered
ROE
86.8%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 48%
$0.12$6.52

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$59.61M
Total Assets
$13.83M
Free Cash Flow
–

Recent news